PlainRecalls
FDA Drug Low Class III Terminated

Hydralazine HCl Tablets, USP, 25mg, Rx only, 100 tablets per carton, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, Distributed by: MAJOR Pharmaceuticals, Livonia, MI, 48152, USA, NDC 0904-6441-61.

Reported: November 20, 2024 Initiated: November 5, 2024 #D-0045-2025

Product Description

Hydralazine HCl Tablets, USP, 25mg, Rx only, 100 tablets per carton, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, Distributed by: MAJOR Pharmaceuticals, Livonia, MI, 48152, USA, NDC 0904-6441-61.

Reason for Recall

Failed Impurities/Degradation Specifications; during routine stability testing for impurities.

Details

Units Affected
25814 tablets
Distribution
Nationwide in the US.
Location
La Vergne, TN

Frequently Asked Questions

What product was recalled?
Hydralazine HCl Tablets, USP, 25mg, Rx only, 100 tablets per carton, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, Distributed by: MAJOR Pharmaceuticals, Livonia, MI, 48152, USA, NDC 0904-6441-61.. Recalled by The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories. Units affected: 25814 tablets.
Why was this product recalled?
Failed Impurities/Degradation Specifications; during routine stability testing for impurities.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 20, 2024. Severity: Low. Recall number: D-0045-2025.